Intrinsic Value of S&P & Nasdaq Contact Us

Cosmos Health Inc. COSM NASDAQ

NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
12/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Cosmos Health Inc. (COSM) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.

Analysts estimate Earnings Per Share (EPS) of $-0.78 and revenue of $0.06B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-1.17 vs est $-0.78 (missed -50%). Analyst accuracy: 67%.

EPS Estimates — COSM

67%
Analyst Accuracy
Fair
1 year compared
Actual vs Estimate
2024 Actual –$1.17 vs Est –$0.78 ▼ 33.3% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.

Revenue Estimates — COSM

99%
Analyst Accuracy
Accurate
1 year compared
Actual vs Estimate
2024 Actual $0.054B vs Est $0.055B ▼ 0.5% off
Revenue Trend
Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message